Albanian‑Finnish startup Bliss raises $270,000 for culturally aware therapy AI
Bliss, a mental health startup founded in Albania and headquartered in Finland, has raised $270,000 in angel funding to develop what it calls culturally intelligent AI infrastructure for therapy. The round combines angel investment and non‑dilutive grants and was led by Keiretsu Forum, Finest Love VC and Plug and Play.
The company said the deal marks the first Albanian‑Finnish startup investment for all three backers. and work across borders. The company notes that more than 800 million people globally outside their country of origin, yet many therapy platforms are built for monolingual, culturally homogeneous markets.
Its premise: translation alone isn’t enough in therapy, where cultural context can shape how people communicate distress and seek support. The platform combines licensed therapists across more than 10 countries with AI‑powered cultural and linguistic matching.
Its longer‑term bet is therapist‑trained digital companions—supervised AI extensions tuned to a therapist’s style, tone and approach—designed to augment, not replace, human care. “We’re not building another chatbot,” founder Jona Doda said. “We’re building AI that understands the cultural layer of mental health, because that’s where most systems fail.” Investors frame the approach as a corrective to generic AI bots.
“People are already turning to AI for emotional support, but most systems were never designed for real care,” said Dr. Ravik Mima, CEO of Keiretsu Forum SEE.
“Bliss is building what the long‑term model should look like: clinically grounded, culturally aware AI with strong human guardrails, and access to world‑class therapists when it matters.” Operating between Tirana and Helsinki, Bliss taps Finland’s deep tech ecosystem and Albania’s emerging startup scene.
Alongside Keiretsu Forum, the round includes Finest Love VC and Silicon Valley’s Plug and Play. Bliss positions its technology as infrastructure to support clinicians and reach diaspora communities and globally distributed workforces. With the fresh backing, the company plans to advance its therapist‑supervised, culturally specialized AI systems.
In a crowded market of AI therapy tools built on generic conversational models, Bliss is staking out a niche that centers cultural context and clinician oversight.